Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples